Kolon TissueGene Faces Delisting In Korea On Invossa Uncertainties

 
• By Jung Won Shin
  
Stock Market Down - Illustration
Kolon Life Shares Drop 22% On Decision To Delist Kolon TissueGene • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia